探讨肾功能障碍和糖尿病对心肌梗死后死亡率的影响:来自不同年龄组综合回顾性队列研究的见解。
Examining the impact of renal dysfunction and diabetes on post-myocardial infarction mortality: insights from a comprehensive retrospective cohort study across different age groups.
机构信息
Department of Cardiology, University of Tartu, Tartu, Estonia.
Centre of Cardiology, North Estonia Medical Centre, Tallinn, Estonia.
出版信息
Scand Cardiovasc J. 2024 Dec;58(1):2395875. doi: 10.1080/14017431.2024.2395875. Epub 2024 Aug 28.
. Chronic kidney disease (CKD) and diabetes mellitus (DM) contribute significantly to cardiovascular disease (CVD) and mortality, with prevalence increasing. The evolving demographic of myocardial infarction (MI) patients, influenced by sedentary lifestyles and advanced medical care, lacks understanding regarding the interplay of CKD, DM, age, and post-MI mortality. This study aims to address this gap by evaluating the long-term impact of CKD and DM on post-MI mortality across age groups. . A retrospective cohort study utilized data from the Estonian Myocardial Infarction Registry (EMIR), Estonian Population Register (EPR), and six major hospitals in Estonia, covering AMI hospitalizations from 2012 to 2019. Statistical analyses included Cox proportional hazards regression models and Kaplan-Meier's curves. . Analysis of 17,085 MI patients revealed age-dependent associations between renal function and mortality. In patients <65 years, even minor decreases in renal function increased both short-term (HR 2.79, 95% CI 1.71-4.55) and long-term (HR 1.24, 95% CI 1.05-1.47) mortality. Mortality significantly increased in patients >80 years only below an estimated glomerular filtration rate (eGFR) of 44 ml/min/1.73 m. Newly diagnosed DM patients exhibited higher mortality rates (average HR 1.53, 95% CI 1.45-1.62), while pre-DM did not significantly differ from non-DM patients across all age groups. The DM-renal failure interaction did not significantly influence mortality. . An age-dependent association between eGFR and post-MI outcomes emphasizes the need for personalized therapeutic approaches considering age-specific eGFR thresholds and comorbidities to optimize patient management.
慢性肾脏病(CKD)和糖尿病(DM)显著增加了心血管疾病(CVD)和死亡率,且其患病率不断上升。由于久坐的生活方式和先进的医疗保健,心肌梗死(MI)患者的人口统计学特征不断发展,但人们对 CKD、DM、年龄和 MI 后死亡率之间的相互作用缺乏了解。本研究旨在通过评估 CKD 和 DM 对各年龄段 MI 后死亡率的长期影响来填补这一空白。
一项回顾性队列研究利用了爱沙尼亚心肌梗死登记处(EMIR)、爱沙尼亚人口登记处(EPR)和爱沙尼亚六家主要医院的数据,涵盖了 2012 年至 2019 年的 AMI 住院患者。统计分析包括 Cox 比例风险回归模型和 Kaplan-Meier 曲线。
对 17085 例 MI 患者的分析显示,肾功能与死亡率之间存在年龄依赖性关联。在<65 岁的患者中,即使肾功能略有下降,也会增加短期(HR 2.79,95%CI 1.71-4.55)和长期(HR 1.24,95%CI 1.05-1.47)死亡率。只有在估计肾小球滤过率(eGFR)<44ml/min/1.73m 时,>80 岁的患者死亡率才会显著增加。新诊断的 DM 患者死亡率更高(平均 HR 1.53,95%CI 1.45-1.62),而在所有年龄组中,DM 前期与非 DM 患者的死亡率无显著差异。DM-肾衰竭相互作用对死亡率没有显著影响。
eGFR 与 MI 后结局之间的年龄依赖性关联强调了需要考虑年龄特异性 eGFR 阈值和合并症,制定个性化的治疗方法,以优化患者管理。